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Vikram M Velker1,2, George B Rodrigues1,2,3*, Robert Dinniwell4, Jeremiah Hwee3 and Alexander V Louie1,2Abstract
Background: Increasing use of IMRT to treat breast and prostate cancers at high risk of regional nodal spread relies
on accurate contouring of targets and organs at risk, which is subject to significant inter- and intra-observer
variability. This study sought to evaluate the performance of an atlas based deformable registration algorithm to
create multi-patient CT based atlases for automated contouring.
Methods: Breast and prostate multi-patient CT atlases (n = 50 and 14 respectively) were constructed to be
consistent with RTOG consensus contouring guidelines. A commercially available software algorithm was evaluated
by comparison of atlas-predicted contours against manual contours using Dice Similarity coefficients.
Results: High levels of agreement were demonstrated for prediction of OAR contours of lungs, heart, femurs, and
minor editing required for the CTV breast/chest wall. CTVs generated for axillary nodes, supraclavicular nodes,
prostate, and pelvic nodes demonstrated modest agreement. Small and highly variable structures, such as internal
mammary nodes, lumpectomy cavity, rectum, penile bulb, and seminal vesicles had poor agreement.
Conclusions: A method to construct and validate performance of CT-based multi-patient atlases for automated
atlas based auto-contouring has been demonstrated, and can be adopted for clinical use in planning of local
regional breast and high-risk prostate radiotherapy.
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Radiotherapy has become a standard of care in the rad-
ical treatment of high-risk prostate disease, and in the
adjuvant treatment of locally advanced breast cancers.
The delivery of radiotherapy has been improved through
technological advances including intensity modulated
radiotherapy (IMRT) and image-guided radiotherapy
(IGRT), both of which have facilitated improved ability
to deliver a given dose to target structures, while minim-
izing dose to organs at risk. Increasingly, IMRT has been
utilized in the delivery of radiotherapy for cancers of the
breast and prostate for normal tissue sparing and im-
proved cosmetic outcomes[1]. However, utilization of* Correspondence: george.rodrigues@lhsc.on.ca
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reproduction in any medium, provided the orthese advanced treatment technologies requires a com-
prehensive and accurate understanding of the cross-
sectional CT anatomy to accurately delineate the target
and normal tissue structures.
The process of target and normal tissue delineation,
known as segmentation or contouring, is subject to sig-
nificant levels of inter- and intra-observer variability in
both the accuracy and reproducibility of structures [2-8].
Accurate delineation of target volumes is critical to ensure
adequate coverage and reduce the risk of local recurrence
[4]. Currently, it is argued that inter-observer variability
amongst radiation oncologists is the most significant con-
tributor to the uncertainty in radiation treatment planning
[9]. Contouring inconsistencies can negate the advantages
of IMRT and may confound clinical trial results. Consen-
sus contouring guidelines have been developed for high
risk breast and prostate cancers to guide the delineation
of the primary and lymph node clinical target volumes,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Manual target volume delineation is also more time con-
suming than traditional planning. Time efficiency and
contouring variability present two potential barriers to the
uptake and utilization of IMRT for breast and prostate
cancer radiotherapy.
A recent technological development in radiation treat-
ment planning is the use of automated atlas-based seg-
mentation (AABS) algorithms to aid in the delineation
of target volumes'. Atlas' refers to a model set of expertly
contoured CT images for one (single-patient) or more
(multi-patient) cases that serve to guide delineation of
target volumes for similar cases. Computerized AABS al-
gorithms utilize CT-based atlases as a template to
deformably register and auto-segment new cases. A pro-
posed advantage of multi-patient atlas is the software
can scan a database of pre-contoured patients to find
one with similar anatomical variation to the new patient
to be contoured, potentially improving the accuracy of
auto-segmentation. Studies evaluating AABS algorithms
in multiple disease sites have previously demonstrated
the potential to improve efficiency and variability associ-
ated with manual segmentation [13-27].
The purpose of this study was to construct a multi-
patient CT-based atlas of expertly contoured high-risk
regional nodal breast and prostate cancer cases, and to
evaluate the performance of a commercially available
AABS for efficiency and accuracy in delineation of clin-
ical target volumes and organs at risk.
Methods
An anonymized CT-database of 124 left and right sided
post-lumpectomy breast cancer patients and 25 high risk
prostate cancer patients simulated for treatment at the
London Regional Cancer Centre between January and
December of 2009. This database, part of the LocStar
(London Ontario Consistently Segmented Tri-purpose
Atlas Resource) project, was utilized to randomly select
25 left breast, 25 right breast, and 14 prostate cancer
cases. Ethics approval for this patient database was
obtained from the University of Western Ontario REB.
CT image datasets were stored according to the Digital
Imaging and Communications in Medicine (DICOM)
standards of practice. Breast cancer patients were simu-
lated supine, arm above head immobilized on a breast
board, while prostate patients were simulated supine
with full bladder using standard technique. Patients with
pacemakers, breast implants, or hip prostheses were ex-
cluded. CT scans were non-contrast enhanced with
3 mm slice thickness.
Post-lumpectomy high risk breast cancer cases were
contoured by a trained Radiation Oncology resident
(VV) with contours reviewed by an expert breast Radi-
ation Oncologist (RD) to ensure conformity with theRTOG Consensus Guidelines for breast radiotherapy
[28]. The CTVs for whole breast and chest wall
(CTVBRCWL), supraclavicular lymph nodes (CTVSCV),
internal mammary nodes (CTVIMN) and axillary levels I,
II, and III (CTVAXI, CTVAX2, CTVAX3) were contoured
according to RTOG guidelines[28]. Additionally, the
lumpectomy cavity (LUMP), and the organs at risk, heart
(H), left lung (LL), and right lung (RL) were delineated.
Using the British Columbia Seroma Clarity Scale, a score
of 1 to 5 was assigned to denote the confidence of the
lumpectomy cavity delineation [29].
High-risk prostate cancer cases were contoured by an
expert genitourinary Radiation Oncologist (GR) according
to the RTOG guidelines. CTV for the prostate (CTVPROS),
pelvic nodes (CTVNODES) and OARs of rectum (R), blad-
der (B), penile bulb (PB), left femur (LF) and right femur
(RF) were delineated.
Contouring and subsequent atlas-construction were
performed utilizing a commercially available, multi-patient
atlas AABS capable software suite (MIM Version 5.2,
MIMVista Corp, Cleveland, Ohio). Manual contouring was
performed using contouring tools including slice-by-slice
deformable registration. The time to manually delineate
each structure was recorded. This created a data set of 25
left breast, 25 right breast, and 14 prostate gold standard
contoured cases.
The atlas building methodology is illustrated in
Figure 1. The left-breast post-lumpectomy atlas was
constructed first. The atlas builder (VV) randomly se-
lected and manually contoured the index case. This Pa-
tient #1 (P1) was added to the atlas library, such that the
library now contained one case (n = 1). Patient #2 (P2)
was then chosen at random to have the AABS algorithm
create a set of automated atlas-predicted contours. Since
the atlas only contained P1, the algorithm selected P1 as
the best match. The CT images of P1 were registered to
fit the uncontoured CT images of P2. The contoured
structures on P1 (CTVs and OARs) were then
deformably registered to fit P2’s anatomy, creating a set
of automated atlas predicted contours, which were
stored as P2PREDICTED.
Next, the manually contoured (gold standard) P2GOLD
was added to the atlas library, now containing two cases
(n + 1), P1GOLD and P2GOLD. The AABS was again used
to create automated contours for Patient #3 (P3), now
able to choose between the two atlas patients (P1GOLD
and P2GOLD) to find the best match for anatomy for P3.
The atlas predicted contours P3PREDICTED were saved,
and then the manually contoured P3GOLD was added to
the atlas. In this fashion, atlas building continued for all
25 patients, which yielded 24 patients with manually de-
lineated contour P(n)GOLD and a atlas predicted P(n)PRE-
DICTED contour set for statistical comparison. This atlas
building and validation method was repeated for the
Figure 1 Atlas building process map.
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cases.
Statistical analysis
Statistical comparison of manually delineated versus
atlas predicted contour sets was performed using
StructSure (Standard Imaging, Wisconsin, USA) to cal-
culate the dice similarity coefficient (DSC). The DSC
metric is a simple spatial overlap index for volumetric
comparison, defined as:
V 1;V 2ð Þ ¼ 2j jV 1∩V 2j = jV 1j þ V 2
where V1 and V2 are the respective volumes of the first
and second contours, and ∩ is the intersection. It follows
that a DSC of 1 equals perfect agreement (overlap), and
a DSC of 0 equals no agreement. DSC for each region of
interest (ROI), contouring times, and seroma scores
were reported using descriptive statistics. Logit trans-
formation of the DSC, such that the score followed a
normal distribution, was performed for quartile ANOVA
analysis and student t-test to determine if atlas perform-
ance improved with increased case number.
Results
High risk breast cancer post-lumpectomy
The high risk left and right-sided breast cases were ana-
lyzed separately. The mean AABS segmentation time
(SD, range) for a single case was 86 s (9, 69-102 s) and
87 s (13, 60-113 s) for left and right, respectively. No sta-
tistically significant difference in automated segmenta-
tion time was found with increased atlas patient
number. Mean manual segmentation time (SD, range)
for a single case was 3177 s (387, 2559-4166 s) and
2905 s (2450 – 3433 s) for left and right, respectively.
Means DSC scores and ranges of targets are reported
in Table 1. Good levels of agreement (mean DSC 0.80to 1) were demonstrated (mean DSC left and right post-
lumpectomy respectively) for CTVBRCWL 0.87 and 0.89
and organs at risk of LL 0.97 and 0.97, RL 0.97 and 0.97,
and H 0.89 and 0.90. Moderate levels of agreement
(mean DSC 0.60-0.79) were demonstrated for nodal tar-
gets CTVAXI 0.72 and 0.75, CTVAX2 0.74 and 0.73,
CTVAX3 0.69 and 0.73, CTVSCV 0.72 and 0.70. Poor
levels of agreement (DSC < 0.60) were demonstrated for
CTVIMN 0.25 and 0.33 and LUMP 0.10 and 0.04. Two
representative breast cases are depicted in Figure 2.
ANOVA quartile analysis showed a statistically signifi-
cant improvement in DSC scores for left breast post-
lumpectomy LL (Quartile 1 to 4, 0.967 to 0.975, p =
0.03), RL (Quartile 2 to 4, 0.967 to 0.978, p = 0.03), and
right breast post-lumpectomy CTVSCV (Quartile 1 to 2,
0.608 to 0.724, p = 0.004). No statistically significant cor-
relation between BC Seroma Score and LUMP DSC was
found.
High risk prostate cancer
For the high-risk prostate atlas, mean AABS segmenta-
tion time (SD, range) for a single case was 134 s (23,
106-179 s). No statistically significant difference in auto-
mated segmentation time was found with increased atlas
patient number. Time for manual contouring of prostate
cases (SD, range) was 354 s (81, 241-525 s).
Means DSC scores and ranges of targets are reported
in Table 2. Good levels of agreement (mean DSC 0.80 to
1) were demonstrated for B 0.84, LF (0.89) and RF
(0.93). Moderate levels of agreement (mean DSC 0.60-
0.79) were demonstrated for CTVPROS 0.71 and
CTVNODES 0.71. Poor levels of agreement (mean DSC <
0.60) were demonstrated for R 0.48, PB 0.39, and SV
0.30. No statistically significant difference in t-test p-
value between the first half and second half of cases
added to the atlas (all p > 0.1). A representative prostate
case is depicted in Figure 3.
Table 1 DSC comparison of atlas predicted ROIs to manually contoured gold standard for the locoregional breast
cancer atlases
Contoured structure ROI name Left breast post lumpectomy
(mean DSC, SD, range)
Right breast post-lumpectomy
(mean DSC, SD, range)
Breast and Chest wall CTVBRCWL 0.87 (0.03, 0.80–0.92) 0.89 (0.04, 0.79–0.94)
Axilla I CTVAX1 0.72 (0.09, 0.43–0.86) 0.75 (0.08, 0.59–0.87)
Axilla II CTVAX2 0.74 (0.06, 0.62–0.87) 0.73 (0.06, 0.63–0.84)
Axilla III CTVAX3 0.69 (0.08, 0.52–0.80) 0.73 (0.07, 0.54–0.83)
Supraclavicular CTVSCV 0.72 (0.07, 0.57–0.82) 0.70 (0.08, 0.52–0.82)
Intramammary Nodes CTVIMN 0.25 (0.14, 0.01–0.59) 0.33 (0.15, 0.03–0.58)
Lumpectomy Cavity LUMP 0.10 (0.20, 0–0.69) 0.04 (0.11, 0–0.89)
Heart H 0.89 (0.03, 0.81–0.92) 0.90 (0.04, 0.81–0.95)
Left Lung LL 0.97 (0.01, 0.96–0.98) 0.97 (0.01, 0.95–0.98)
Right Lung RL 0.97 (0.01, 0.95–0.99) 0.97 (0.01, 0.96–0.98)
N = 25 Left-, 25 Right- High Risk Post Lumpectomy Cases.
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Adoption of AABS has the potential to improve the effi-
ciency of workflow and segmentation conformity with
consensus guidelines. This is the first study to test a
multi-patient CT-atlas based auto-segmentation ap-
proach for local regional breast and high risk prostate
cancers, two of the most common high volume disease
sites treated by radiation oncologists. We have demon-
strated a method to construct a multi-patient CT-based
contouring atlas and have validated the performance of
a commercially available auto-segmentation algorithm
for these disease sites.
In the local regional breast scenario tested, the algo-
rithm performed well for lung and heart, and these con-
tours could likely be used with no, or minimal editing.
For breast and chest wall, agreement was acceptable
with high mean DSC scores (0.87 and 0.89), the majority
of variation occurring in the posterior lateral border,
where the medial edge of the latissimus dorsi provides a
partial anatomical landmark. These results are consistent
with a single-patient atlas based auto-segmentation
study of whole breast by Reed et al. [19] which reported
DSC of 0.94. Manual correction was required in the in-
ferior and superior slices, yet auto-contouring of the
breast surface and posterior chest wall were highly ac-
curate and would likely not require any editing to be
clinically appropriate.
Automated lymph node contours demonstrated mod-
est levels of agreement, and require manual revision, es-
pecially for the designated supraclavicular compartment.
Results for lymph node contouring were consistent with
the modest levels of inter-observer agreement amongst
experts in previous contouring studies [30], and can be
interpreted as superior to the mean percentage overlap
of the RTOG consensus guideline project by Li et al. [4].
There were low levels of conformity for highly variable
and small volume structures such as the IMC chain andlumpectomy cavity. These delineations are based on
judgment and subtle anatomical cues, and it is advised
that these structures be contoured manually [25].
The use of a multi-patient approach to account for
anatomical variation is different than the approach used
by Anders et al. [25], where 3 separate individual atlases
on the basis of breast volume (small, medium, large)
were manually matched prior to AABS. They reported
that breast shape, and not absolute volume, appeared to
be more important and that a STAPLE (simultaneous
truth and performance level estimation) contour gener-
ated from nine random patients was a superior template
[25]. We have demonstrated minor improvements in
lung contouring with increasing patient number, but no
statistically significant improvement in prediction of tar-
get volume delineation was found beyond an atlas size
of 12 individuals. This perhaps suggests an upper limit
to the ability of the software algorithm to register the
CT anatomy, and the number of cases required to bene-
fit from the multi-patient atlas approach.
For high-risk prostate cases, the algorithm performed
well for auto-delineation of the bladder and femurs. Pre-
dicted bladder contours were most variable at the blad-
der neck. For the rectum and penile bulb, conformity
was low, with ambiguity of the superior and inferior
limits of contouring. Prostate and pelvic nodal targets
had moderate agreement, but would require manual cor-
rection and discretionary inclusion of a portion of the
seminal vesicles. Qualitatively, prediction of pelvic nodal
contours preserved the pattern of delineation in the con-
sensus atlas and respected bony radial borders, however
manual revision of iliac and pelvic vessels margins was
required. A significant performance improvement with
increased case number was not observed.
This study brings to issue the limitations of AABS and
evaluation of contouring studies. We assigned a single
expert to delineate the structures based on the RTOG
Figure 2 Atlas-predicted contouring for high risk breast cancer post lumpectomy. Representative slices of two contoured right breast-post
lumpectomy cases comparing atlas predicted auto contours (bold outline) to manual contoured standard (thin outline with colourwash). Atlas
subjects #5 (left images) and #14 (right images). ROIs demonstrated are CTVBRCWL (purple), CTVAX1 (yellow), CTVAX2 (pink), CTVAX3 (dark blue),
CTVSCV (teal), LUMP (orange), H (red), LL(light yellow), RL(green). Bottom panels demonstrate the high degree of variability in seroma (LUMP)
prediction with the atlas being unable to predict the subtle seroma (left images, DSC = 0) while contouring a more readily identifiable seroma
with reasonable accuracy (right images, DSC = 0.89).
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Table 2 DSC comparison of atlas predicted ROIs to
manually contoured gold standard for high risk prostate
cancer atlas
Contoured structure ROI name High risk prostate
(mean DSC, SD, range)
Prostate CTVPROS 0.71 (0.12, 0.35–0.84)
Pelvic Nodes CTVNODES 0.71 (0.07, 0.58–0.79)
Bladder B 0.83 (0.10, 0.63–0.95)
Rectum R 0.48 (0.19, 0.17–0.76)
Seminal Vesicles SV 0.30 (0.31, 0–0.79)
Penile Bulb PB 0.39 (0.22, 0–0.67)
Left Femoral Head LF 0.89 (0.09, 0.63–0.95)
Right Femoral Head RF 0.93 (0.03, 0.86–0.96)
N = 14 High Risk Prostate Cancer Cases.
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algorithm performance, and intra-observer variation is
generally less of a factor than inter-observer variability.
In addition, although the current data set is from a sin-
gle institution, standard simulation techniques were uti-
lized and as such we believe will be applicable in other
centers as well. As previous investigations have demon-
strated that variances in segmentation have significant
dosimetric consequences [4], it is recognized that only
segmentation was assessed in this study. Although
RTOG guidelines were utilized, this atlas building and
evaluation method can be utilized by any clinician toFigure 3 Atlas-predicted contouring for high risk prostate cancer. Sam
predicted auto contours (bold outline) to manual contoured standard (thin
CTVNODES (red), B (Green), R (Orange), PB (dark purple), SV (cyan), LF and RFcompile and create an atlas of their cases to reflect their
individual contouring practices.
Although we have utilized the DSC, a volumetric
based concordance index, there is no consensus in the
literature as to the appropriate metric for the analysis
and comparison of contours [31]. Limitation of DSC is
sensitivity to variability for small volume structures and
that it does not quantitatively describe where within the
segmented volume the majority of the variation occurs,
assigning equal importance to all voxels. This is particu-
larly evident in the comparison of large structures (ie.
breast/chest wall) where the majority of volumetric devi-
ation was in the superior and inferior slices, while inter-
mediary slices were contoured with high fidelity. The
integration of recently developed penalty metric scores
that penalize for contouring variation near critical struc-
tures where the dosimetric consequence is more severe
may improve on this metric in future studies [32].
We have demonstrated that the use of AABS algo-
rithm for deformable registration is computationally
time efficient. Although the time to correct auto-
contours by multiple observers was not captured, and
would be expected to vary widely, the MIM AABS tool
has been previously demonstrated in head and neck and
prostate bed contouring to afford significant time sav-
ings [17,22]. There is a question as to whether the use of
AABS will bias a radiation oncologist’s contours, though
our group has previously demonstrated, in the post-ple slices of contoured high risk prostate cases comparing atlas
outline with colourwash). ROIs demonstrated are CTVPROS (purple),
(dark blue).
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ment between edited auto-contours and manually gener-
ated contours, and lower levels of inter-observer
variability [22]. Thus, AABS may hold promise for future
application in clinical trials to reduce contouring vari-
ability amongst centres. A potential criticism of AABS is
that while we believe an atlas based on the RTOG guide-
lines would be expected to improve accuracy by redu-
cing the variability amongst multiple observers, we
cannot confidently say that the guidelines do not bias
away from the ‘truth’. Therefore, it is imperative that
when auto-contouring is utilized, the contours must be
reviewed and edited by a skilled radiation oncologist
with an understanding of the patient’s clinical and
pathological context.
Conclusions
This is the first study to demonstrate the building of
RTOG guidelines compliant CT-based multi-patient at-
lases for local regional breast and high risk prostate cancer
treatment planning. Based on this performance evaluation
of the MIM AABS algorithm, we recommend that it be
considered for clinical use in the routine delineation of
the lungs, heart, and bilateral femora with no editing re-
quired. Clinical target volumes generated for the breast/
chest wall, axillary lymph nodes, prostate and pelvic nodes
require review and editing by a radiation oncologist prior
to clinical use. Bladder and rectum contours should be
reviewed and may require minor editing. Small, highly
variable structures such as lumpectomy cavities, the IMC
chain, penile bulb, and seminal vesicles should be
contoured manually. AABS algorithms hold considerable
promise to improve efficiency of the contouring process
and improve conformity with guidelines amongst multiple
observers, although further advances in these technologies
will continue to require rigorous performance evaluation
prior to their adoption in clinical use.
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